Drug majors Roche India and Cipla on Monday announced the launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk. “The first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a … Continue reading Roche India launches first batch of antibody cocktail for treating Covid-19